Steven Arnold, MD: Assessing AMX0035 Efficacy in Alzheimer Disease
The managing director of the Interdisciplinary Brain Center at Massachusetts General Hospital discussed the process of determining the best situations for use of AMX0035.
Steven Arnold, MD: Assessing AMX0035 in Alzheimer Disease
The managing director of the Interdisciplinary Brain Center at Massachusetts General Hospital discussed the potential of AMX0035 for the treatment of Alzheimer disease and other neurological diseases.
Steven Arnold, MD: Phase 2 PEGASUS Trial in Alzheimer Disease
The managing director of the Interdisciplinary Brain Center at Massachusetts General Hospital discussed the trial design and outcomes of the PEGASUS trial of AMX0035.